Roots Analysis

SEPTEMBER 18, 2023

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

Pharmaceutical Technology

JUNE 23, 2022

During the peak of the Covid-19 pandemic this challenge reached new heights, as pharmaceutical firms around the world mobilised the full might of their resources to try and identify, develop, and trial a wide range of vaccines and therapeutics to alleviate the lethal threat posed by the virus. Decentralised trials continue to be in-demand.

Trials 130

Trials Clinical Trials Clinical Trials Drug Delivery 130

pharmaphorum

MARCH 14, 2022

This morning, Sandoz announced it has acquired medical and drug delivery device specialist Coalesce Product Development, bolstering its capabilities for the development of respiratory medicines and ‘complex’ generics.

Sales 104

Sales Drug Delivery Marketing Production 104

XTalks

SEPTEMBER 23, 2020

The pen needle is being marketed by HTL-STREFA , a subsidiary of MTD Medical Technology and Devices SA , which is a world-leading Swiss medical technology/medical device group that develops, manufactures and sells safety lancets, personal lancets and pen needles for insulin injection.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

XTalks

NOVEMBER 30, 2023

Patient-centric co-design refers to an approach where patients or end-users are actively involved with healthcare professionals, designers and other stakeholders to develop healthcare services or products. They also shared strategies for integrating this approach into product development, ultimately aiming to improve patient outcomes.

Life Science 22

Life Science Production Development Drug Delivery 22

pharmaphorum

NOVEMBER 17, 2021

The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

Drugs 52

Drugs Drug Delivery Engineer Production 52

pharmaphorum

OCTOBER 12, 2022

Sustainability for Injectable Delivery Devices. Primary Packaging Development. Connected Drug Delivery Devices. Delve into the considerations for material components for the development of primary packaging. Mitali Aon, VP and Global Head of Device Development, Sanofi. find out more at [link].

Drugs 52

Drugs Packaging Packaging Drug Delivery 52

Roots Analysis

FEBRUARY 22, 2022

Further, in order to improve the quality of life in these patients, companies have developed novel devices capable of delivering a variety of formulations of different drugs / therapies, in an efficient and relatively simple manner. Autoinjector As Emerging Drug Delivery Device.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

pharmaphorum

JANUARY 12, 2021

They also offer the potential for self-administration at home rather than in a health setting, making compliance with booster dosage potentially higher.”. This is particularly important in developing countries, where access to cold-chain is limited,” said Channon. There are other theoretical advantages as well.

Licensing 119

Licensing Licensing Vaccination Vaccine 119

The Pharma Data

OCTOBER 27, 2020

“Applying 3a’s proprietary enhanced RNA technology to PCR testing was a logical next step in our product development pipeline,” said Dr. . “We are currently developing two saliva-based tests to detect SARS-CoV-2 RNA. . VANCOUVER, BC / ACCESSWIRE / October 28, 2020 / XPhyto Therapeutics Corp.

RNA 52

RNA Drug Delivery Production In-Vitro 52

Roots Analysis

SEPTEMBER 13, 2023

Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drug delivery systems.

Development 40

Development Antibody Protein Drug Delivery Systems 40

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

XTalks

AUGUST 30, 2022

Developing strategies can often fall under the responsibilities of directors and managers of companies. The pharmaceutical industry deals with threats such as product liability, cyberthreats, supply chain disruptions, competition from generic drugs and more. Therefore, strategic intent is vital when making decisions.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

XTalks

JULY 5, 2022

A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Novartis trains and guides associates with a structured program consisting of ethics, risk and compliance.

Life Science 52

Life Science Compliance Packaging Packaging 52

XTalks

MAY 23, 2024

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. These include broad-spectrum sunscreens, protective clothing and innovative skincare products developed using antioxidants and other protective agents. How is Medicus Pharma innovating in this space?

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

XTalks

JUNE 11, 2024

The US Food and Drug Administration (FDA) recently approved Boston Scientific’s Agent drug-coated balloon (DCB) for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease (CAD). Drug-eluting stents (DES): DES reduce the incidence of restenosis and are coated with drugs that inhibit scar tissue growth.

Drugs 52

Drugs Drug Delivery Cardiology Marketing 52

Roots Analysis

MAY 24, 2024

In the dynamic landscape of the healthcare sector, the evolution of drug delivery systems plays a significant role in transforming the management of chronic diseases. These devices reduce injection anxiety, and are useful for patients who prefer a hands-free drug delivery experience.

Drug Delivery 40

Drug Delivery Containment Contamination Production 40

Delveinsight

JANUARY 22, 2021

Thrombocytopenia pipeline possesses potential drugs in mid-stage developments to be approved shortly. The growth of the market size can be labelled pretty much modest as the demand of the novel drugs can be witnessed rising owing to no available cure in the Thrombocytopenia treatment market.

Marketing 65

Marketing Drugs Antibody Compliance 65

pharmaphorum

JUNE 22, 2021

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares to give a much-anticipated update to shareholders tomorrow. So far, all the other antibodies are also delivered by intravenous infusion.

Antibody 52

Antibody Protein Drug Delivery Drugs 52

Roots Analysis

MARCH 9, 2022

1] The desired function of excipient in formulation of the medicinal product is to carry the active component to the target site with an active contribution in improving its biological effect, stability, appearance and patient compliance. [2]. Biopharmaceutical Excipient Manufacturing Market. Biopharmaceutical Excipient Manufacturing Market.

Manufacturing 52

Manufacturing Marketing Contract Manufacturing Protein 52

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. About BetterLife Pharma Inc. BetterLife Pharma Inc.

Containment 52

Containment Drug Delivery Compliance Marketing 52

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

The Pharma Data

OCTOBER 14, 2020

15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.

Drugs 40

Drugs Allergies Cardiology Medicine 40

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. This was a topic at the December Food and Drug Law Institute conference on Current Developments in Digital Health Technology and Regulation.

Regulation 59

Regulation Production Drug Delivery Marketing 59

The Pharma Data

DECEMBER 17, 2020

Opioid dependence is a serious, chronic, relapsing disease associated with a disproportionate amount of drug-related harm that includes infectious diseases and other health problems, mortality, unemployment, homelessness and social exclusion 6. Fredrik Joabsson, Chief Business Development Officer Tel. +46 About Buvidal.

Clinical Trials 52

Clinical Trials Clinical Trials Drug Delivery Production 52

The Pharma Data

JANUARY 16, 2021

molecular assessment within two weeks after receiving plasmids, to advance R&D process for antibody drug development. With its sophisticated quality and service systems, JS Bio will accelerate the application of Etta Biotech’s products in antibody drug development in the industry. JS Bio’s parent company.

Protein 52

Protein Production Antibody In-Vitro 52

The Pharma Data

JANUARY 18, 2021

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to announce that Health Canada has confirmed that 2-bromo-LSD is not a controlled substance. VANCOUVER, Jan.

Containment 40

Containment Production Drug Delivery Regulation 40

The Pharma Data

NOVEMBER 4, 2020

Thoresen holds a law degree from the top-ranked University of Oslo and core competencies in strategy and organizational development, operational execution, and industry and government relations. Thoresen is an important addition to XPhyto’s board of directors. About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.

Drug Delivery 40

Drug Delivery Production Manufacturing Development 40

The Pharma Data

JANUARY 27, 2021

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, announces it has entered into an agreement with Eurofins Discovery for TD-0148A’s U.S. VANCOUVER, Jan.

In-Vitro 52

In-Vitro Containment Drugs Production 52

The Pharma Data

JANUARY 3, 2021

NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that Ocumension Therapeutics, a China-based ophthalmic pharmaceutical company traded on the Stock Exchange of Hong Kong (1477.HK), WATERTOWN, Mass., HK), has made a $15.7 million equity investment in EyePoint.

Production 52

Production Sales Development Licensing 52

The Pharma Data

DECEMBER 14, 2020

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC ’s (“Transcend”) manufacturing patent “Process of synthesizing 2-Bromo-LSD.”.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

XTalks

FEBRUARY 24, 2021

For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Droplet Micron was developed with the understanding that injections are more than just a moment. The injection experience is an often-overlooked aspect in insulin administration.

Insulin 64

Insulin Production Drug Delivery Marketing 64

pharmaphorum

JUNE 10, 2021

It can be reasonably argued that the upfront research and development of vaccine technologies leveraging mRNA – which can be widely applied against a number of viruses – will be the solutions that end our current pandemic and will effectively position society to be ready for the next. What’s Next: How Should Pharma Companies Respond?

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

Roots Analysis

JANUARY 27, 2025

This has led to the growing research and development towards the development of biologics for therapy purpose. In order to help circumvent these disadvantages, several drug delivery devices, which enable patients to self-administer drugs through subcutaneous route are now being developed.

Marketing 40

Marketing Drug Delivery Development Protein 40